TY - JOUR T1 - Evidence for <em>GRN</em> as part of a neuroinflammatory mechanism connecting common neurodegenerative diseases JF - medRxiv DO - 10.1101/2020.12.04.20243600 SP - 2020.12.04.20243600 AU - Mike A. Nalls AU - Cornelis Blauwendraat AU - Lana Sargent AU - Dan Vitale AU - Hampton Leonard AU - Hirotaka Iwaki AU - Yeajin Song AU - Sara Bandres-Ciga AU - Kevin Menden AU - Faraz Faghri AU - Peter Heutink AU - Mark R. Cookson AU - Andrew B. Singleton Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/12/07/2020.12.04.20243600.abstract N2 - Background Previous research using genome wide association studies (GWAS) has identified variants that may contribute to lifetime risk of multiple neurodegenerative diseases. However, whether there are common mechanisms that link neurodegenerative diseases is uncertain. Here, we focus on one gene, GRN, encoding progranulin, and the potential mechanistic interplay between genetic risk, gene expression in the brain and inflammation across multiple common neurodegenerative diseases.Methods We utilized GWAS, expression quantitative trait locus (eQTL) mapping and Bayesian colocalization analyses to evaluate potential causal and mechanistic inferences. We integrate various molecular data types from public resources to infer disease connectivity and shared mechanisms using a data driven process.Findings eQTL analyses combined with GWAS identified significant functional associations between increasing genetic risk in the GRN region and decreased expression of the gene in Parkinson’s, Alzheimer’s and amyotrophic lateral sclerosis. Additionally, colocalization analyses show a connection between blood based inflammatory biomarkers relating to platelets and GRN expression in the frontal cortex.Interpretation GRN expression mediates neuroinflammation function related to general neurodegeneration. This analysis suggests shared mechanisms for Parkinson’s, Alzheimer’s and amyotrophic lateral sclerosis.Funding National Institute on Aging, National Institute of Neurological Disorders and Stroke, and the Michael J. Fox Foundation.Competing Interest StatementThis works was carried out in part by NIH contractors.Funding StatementThis work was supported in part by the Intramural Research Program of the National Institute on Aging and National Institute of Neurological Disorders and Stroke (project number Z01-AG000949-02). Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Research is based on meta-analysis summary stats where IRB data is not needed, but this project is covered by relevant NIH/NIA IRBs.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAvailable here [https://drive.google.com/file/d/1VVYpnhK00-R4Ah9MROcusF1U0hgjdIfx/view?usp=sharing]. https://drive.google.com/file/d/1VVYpnhK00-R4Ah9MROcusF1U0hgjdIfx/view?usp=sharing ER -